These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38796461)

  • 1. Comparison of testing methods assessing the in vitro efficacy of the combination of aztreonam with avibactam on multidrug-resistant Gram-negative bacilli.
    Deckers C; Bélik F; Denis O; Bogaerts P; Montesinos I; Berhin C; Bouchahrouf W; Hoebeke M; Evrard S; Gilliard N; Okur M; Huang TD
    Ann Clin Microbiol Antimicrob; 2024 May; 23(1):47. PubMed ID: 38796461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Susceptibility Testing Methods for Aztreonam and Ceftazidime-Avibactam Combination Therapy on Extensively Drug-Resistant Gram-Negative Organisms.
    Khan A; Erickson SG; Pettaway C; Arias CA; Miller WR; Bhatti MM
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0084621. PubMed ID: 34424044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
    Marshall S; Hujer AM; Rojas LJ; Papp-Wallace KM; Humphries RM; Spellberg B; Hujer KM; Marshall EK; Rudin SD; Perez F; Wilson BM; Wasserman RB; Chikowski L; Paterson DL; Vila AJ; van Duin D; Kreiswirth BN; Chambers HF; Fowler VG; Jacobs MR; Pulse ME; Weiss WJ; Bonomo RA
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Dilution Susceptibility Testing Methods for Aztreonam in Combination with Avibactam against Enterobacterales.
    Kelley CJ; Kennedy-Mendez A; Walser ON; Thwaites MT; Arhin FF; Pillar CM; Hufnagel DA
    Microbiol Spectr; 2022 Dec; 10(6):e0360122. PubMed ID: 36342288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the MTS™ aztreonam-avibactam strip (Liofilchem) on New Delhi metallo-β-lactamase-producing Enterobacterales.
    Emilie CM; Alice CM; Marine G; Farfour E; Pourbaix A; Dortet L; Lucie L; Marc V
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):777-784. PubMed ID: 38277033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter evaluation of activity of aztreonam in combination with avibactam, relebactam, and vaborbactam against metallo-β-lactamase-producing carbapenem-resistant gram-negative bacilli.
    Tao L; Dahlquist A; Harris H; Jacobs E; Wenzler E; Simner PJ; Humphries R
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0069324. PubMed ID: 39158279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro.
    Lin Q; Zou H; Chen X; Wu M; Ma D; Yu H; Niu S; Huang S
    BMC Microbiol; 2021 Feb; 21(1):60. PubMed ID: 33618662
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Huang YS; Chen PY; Chou PC; Wang JT
    Microbiol Spectr; 2023 Jun; 11(3):e0056923. PubMed ID: 37154758
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Wang W; Huang S; Zou C; Ding Y; Wang H; Pu S; Liao Y; Du H; Wang D; Chen L; Niu S
    Front Cell Infect Microbiol; 2021; 11():755763. PubMed ID: 34778107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of broth disk elution method for aztreonam in combination with ceftazidime/avibactam against
    Song P; Xu J; Jiang L; Zhang Q; Liu C
    Microbiol Spectr; 2024 Oct; 12(10):e0095324. PubMed ID: 39225487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ceftazidime-avibactam against gram-negative bacteria in patients with bacteremia and skin and soft-tissue infections in Colombia 2019-2021.
    Lemos-Luengas EV; Rentería-Valoyes S; Muñoz DMA; Gonzalez CKG; Guerrón-Gómez G; Ramos-Castaneda JA
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116235. PubMed ID: 38458096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ceftazidime/avibactam against Gram-negative strains in Colombia 2014-2018.
    Lemos-Luengas EV; Rentería-Valoyes S; Cárdenas-Isaza P; Ramos-Castaneda JA
    J Glob Antimicrob Resist; 2022 Jun; 29():141-146. PubMed ID: 35257971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against
    Han R; Yang X; Yang Y; Guo Y; Yin D; Ding L; Wu S; Zhu D; Hu F
    Microbiol Spectr; 2022 Feb; 10(1):e0109221. PubMed ID: 35019685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical laboratory method to determine ceftazidime-avibactam-aztreonam synergy in patients with New Delhi metallo-beta-lactamase (NDM)-producing Enterobacterales infection.
    Rawson TM; Brzeska-Trafny I; Maxfield R; Almeida M; Gilchrist M; Gonzalo X; Moore LS; Donaldson H; Davies F
    J Glob Antimicrob Resist; 2022 Jun; 29():558-562. PubMed ID: 35131508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: A single-centre study.
    Wei J; Zou C; Wang D; Huang A; Niu S
    J Glob Antimicrob Resist; 2020 Sep; 22():448-451. PubMed ID: 32387260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era.
    Bianco G; Boattini M; Comini S; Casale R; Iannaccone M; Cavallo R; Costa C
    Eur J Clin Microbiol Infect Dis; 2022 Apr; 41(4):573-580. PubMed ID: 35061145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
    López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.
    Biedenbach DJ; Kazmierczak K; Bouchillon SK; Sahm DF; Bradford PA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4239-48. PubMed ID: 25963984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019.
    Rossolini GM; Stone G; Kantecki M; Arhin FF
    J Glob Antimicrob Resist; 2022 Sep; 30():214-221. PubMed ID: 35760303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter Evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam Broth Disk Elution Test.
    Harris H; Tao L; Jacobs EB; Bergman Y; Adebayo A; Tekle T; Lewis S; Dahlquist A; Abbey TC; Wenzler E; Humphries R; Simner PJ
    J Clin Microbiol; 2023 May; 61(5):e0164722. PubMed ID: 37070979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.